LINK ALTERNATIF MBL77 - AN OVERVIEW

Not all individuals with CLL need therapy. Even with all the latest developments, the iwCLL still suggests watchful observation for people with asymptomatic condition.86 This suggestion is based on at least two randomized trials evaluating observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both